DNA vaccination strategy targets epidermal dendritic cells, initiating their migration and induction of a host immune response

Molecular Therapy Methods and Clinical Development

Volumn 1, Issue , 2014, Pages 14054-

  Smith, Trevor RF ^a   Schultheis, Katherine ^a   Kiosses, William B ^b   Amante, Dinah H ^a   Mendoza, Janess M ^a   Stone, John C ^a   McCoy, Jay R ^a   Sardesai, Niranjan Y ^a   Broderick, Kate E ^a  

^a Inovio Pharmaceuticals Inc   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; FLUORESCEIN ISOTHIOCYANATE; IMMUNOGLOBULIN G; RED FLUORESCENT PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; CELL MIGRATION; CELL POPULATION; CELL STRUCTURE; CELL SUSPENSION; CONFOCAL LASER SCANNING MICROSCOPY; DENDRITIC CELL; DNA IMMUNIZATION; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; GUINEA PIG MODEL; HISTOCOMPATIBILITY; HOST; HUMORAL IMMUNITY; IN VIVO GENE TRANSFER; IN VIVO STUDY; KERATINOCYTE; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; REPORTER GENE; SKIN BIOPSY; STRATUM CORNEUM;

EID: 85015637311     PISSN: None     EISSN: 23290501     Source Type: Journal    
DOI: 10.1038/mtm.2014.54     Document Type: Article

References (53)

1. 1 Banchereau, J, Steinman, RM, Dendritic cells and the control of immunity. Nature 392 (1998), 245–252.
2. 2 Bins, AD, Jorritsma, A, Wolkers, MC, Hung, CF, Wu, TC, Schumacher, TN, et al. A rapid and potent DNA vaccination strategy defined by in vivo monitoring of antigen expression. Nat Med 11 (2005), 899–904.
3. 3 Broderick, KE, Shen, X, Soderholm, J, Lin, F, McCoy, J, Khan, AS, et al. Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device. Gene Ther 18 (2011), 258–265.
4. 4 Song, JM, Kim, YC, Barlow, PG, Hossain, MJ, Park, KM, Donis, RO, et al. Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles. Antiviral Res 88 (2010), 244–247.
5. 5 Bråve, A, Nyström, S, Roos, AK, Applequist, SE, Plasmid DNA vaccination using skin electroporation promotes poly-functional CD4 T-cell responses. Immunol Cell Biol 89 (2011), 492–496.
6. 6 Bakari, M, Aboud, S, Nilsson, C, Francis, J, Buma, D, Moshiro, C, et al. Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania. Vaccine 29 (2011), 8417–8428.
7. 7 Drabick, JJ, Glasspool-Malone, J, King, A, Malone, RW, Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 3 (2001), 249–255.
8. 8 Glenn, GM, Taylor, DN, Li, X, Frankel, S, Montemarano, A, Alving, CR, Transcutaneous immunization: a human vaccine delivery strategy using a patch. Nat Med 6 (2000), 1403–1406.
9. 9 Weiner, DB, DNA vaccines: crossing a line in the sand. Introduction to special issue. Vaccine 26 (2008), 5073–5074.
10. 10 Guo, S, Donate, A, Basu, G, Lundberg, C, Heller, L, Heller, R, Electro-gene transfer to skin using a noninvasive multielectrode array. J Control Release 151 (2011), 256–262.
11. 11 Roos, AK, Eriksson, F, Timmons, JA, Gerhardt, J, Nyman, U, Gudmundsdotter, L, et al. Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment. PLoS One, 4, 2009, e7226.
12. 12 Klein, RM, Wolf, ED, Wu, R, Sanford, JC, High-velocity microprojectiles for delivering nucleic acids into living cells. 1987. Biotechnology 24 (1992), 384–386.
13. 13 Yang, NS, Burkholder, J, Roberts, B, Martinell, B, McCabe, D, In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA 87 (1990), 9568–9572.
14. 14 Oosterhuis, K, van den Berg, JH, Schumacher, TN, Haanen, JB, DNA vaccines and intradermal vaccination by DNA tattooing. Curr Top Microbiol Immunol 351 (2012), 221–250.
15. 15 Prausnitz, MR, Microneedles for transdermal drug delivery. Adv Drug Deliv Rev 56 (2004), 581–587.
16. 16 Sardesai, NY, Weiner, DB, Electroporation delivery of DNA vaccines: prospects for success. Curr Opin Immunol 23 (2011), 421–429.
17. 17 van Drunen Littel-van den Hurk, S, Hannaman, D, Electroporation for DNA immunization: clinical application. Expert Rev Vaccines 9 (2010), 503–517.
18. 18 Hirao, LA, Wu, L, Satishchandran, A, Khan, AS, Draghia-Akli, R, Finnefrock, AC, et al. Comparative analysis of immune responses induced by vaccination with SIV antigens by recombinant Ad5 vector or plasmid DNA in rhesus macaques. Mol Ther 18 (2010), 1568–1576.
19. 19 Diehl, MC, Lee, JC, Daniels, SE, Tebas, P, Khan, AS, Giffear, M, et al. Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteers. Hum Vaccin Immunother 9 (2013), 2246–2252.
20. 20 El-Kamary, SS, Billington, M, Deitz, S, Colby, E, Rhinehart, H, Wu, Y, et al. Safety and tolerability of the Easy Vax™ clinical epidermal electroporation system in healthy adults. Mol Ther 20 (2012), 214–220.
21. 21 Donate, A, Coppola, D, Cruz, Y, Heller, R, Evaluation of a novel non-penetrating electrode for use in DNA vaccination. PLoS One, 6, 2011, e19181.
22. 22 Lin, F, Shen, X, McCoy, JR, Mendoza, JM, Yan, J, Kemmerrer, SV, et al. A novel prototype device for electroporation-enhanced DNA vaccine delivery simultaneously to both skin and muscle. Vaccine 29 (2011), 6771–6780.
23. 23 Lin, F, Shen, X, Kichaev, G, Mendoza, JM, Yang, M, Armendi, P, et al. Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device. Hum Gene Ther Methods 23 (2012), 157–168.
24. 24 Mendoza, J, Amante, D, Kichaev, G, Knott, C, Kiosses, W, Smith, T, et al. Elucidating the kinetics of expression and immune cell infiltration resulting from plasmid gene delivery enhanced by surface dermal electroporation. Vaccines 1 (2013), 384–397.
25. 25 Cashman, KA, Broderick, KE, Wilkinson, ER, Shala, CI, Bell, TM, Shurtleff, AC, et al. Enhanced efficacy of a codon-optimized DNA vaccine encoding the glycoprotein precursor gene of lassa virus in a guinea pig disease model when delivered by dermal electroporation. Vaccines 1 (2013), 262–277.
26. 26 Kim, YC, Jarrahian, C, Zehrung, D, Mitragotri, S, Prausnitz, MR, Delivery systems for intradermal vaccination. Curr Top Microbiol Immunol 351 (2012), 77–112.
27. 27 Hirao, LA, Draghia-Akli, R, Prigge, JT, Yang, M, Satishchandran, A, Wu, L, et al. Multivalent smallpox DNA vaccine delivered by intradermal electroporation drives protective immunity in nonhuman primates against lethal monkeypox challenge. J Infect Dis 203 (2011), 95–102.
28. 28 Ito, K, Ito, K, Shinohara, N, Kato, S, DNA immunization via intramuscular and intradermal routes using a gene gun provides different magnitudes and durations on immune response. Mol Immunol 39 (2003), 847–854.
29. 29 Hohlfeld, R, Engel, AG, The immunobiology of muscle. Immunol Today 15 (1994), 269–274.
30. 30 Tüting, T, Storkus, WJ, Falo, LD Jr, DNA immunization targeting the skin: molecular control of adaptive immunity. J Invest Dermatol 111 (1998), 183–188.
31. 31 Torres, CA, Iwasaki, A, Barber, BH, Robinson, HL, Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol 158 (1997), 4529–4532.
32. 32 Barbero, AM, Frasch, HF, Pig and guinea pig skin as surrogates for human in vitro penetration studies: a quantitative review. Toxicol In Vitro 23 (2009), 1–13.
33. 33 Panchagnula, R, Stemmer, K, Ritschel, WA, Animal models for transdermal drug delivery. Methods Find Exp Clin Pharmacol 19 (1997), 335–341.
34. 34 Healey, DG, Baker, D, Gschmeissner, SE, Turk, JL, An antigenic determinant common to lymphocytes and Langerhans cells of the guinea pig. Int Arch Allergy Appl Immunol 82 (1987), 120–124.
35. 35 Randolph, GJ, Angeli, V, Swartz, MA, Dendritic-cell trafficking to lymph nodes through lymphatic vessels. Nat Rev Immunol 5 (2005), 617–628.
36. 36 Allan, RS, Waithman, J, Bedoui, S, Jones, CM, Villadangos, JA, Zhan, Y, et al. Migratory dendritic cells transfer antigen to a lymph node-resident dendritic cell population for efficient CTL priming. Immunity 25 (2006), 153–162.
37. 37 Condon, C, Watkins, SC, Celluzzi, CM, Thompson, K, Falo, LD Jr, DNA-based immunization by in vivo transfection of dendritic cells. Nat Med 2 (1996), 1122–1128.
38. 38 Porgador, A, Irvine, KR, Iwasaki, A, Barber, BH, Restifo, NP, Germain, RN, Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization. J Exp Med 188 (1998), 1075–1082.
39. 39 Grønevik, E, Tollefsen, S, Sikkeland, LI, Haug, T, Tjelle, TE, Mathiesen, I, DNA transfection of mononuclear cells in muscle tissue. J Gene Med 5 (2003), 909–917.
40. 40 Nicolas, JF, Guy, B, Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 7 (2008), 1201–1214.
41. 41 Laddy, DJ, Yan, J, Khan, AS, Andersen, H, Cohn, A, Greenhouse, J, et al. Electroporation of synthetic DNA antigens offers protection in nonhuman primates challenged with highly pathogenic avian influenza virus. J Virol 83 (2009), 4624–4630.
42. 42 Petkov, SP, Heuts, F, Krotova, OA, Kilpelainen, A, Engström, G, Starodubova, ES, et al. Evaluation of immunogen delivery by DNA immunization using non-invasive bioluminescence imaging. Hum Vaccin Immunother 9 (2013), 2228–2236.
43. 43 Vandermeulen, G, Staes, E, Vanderhaeghen, ML, Bureau, MF, Scherman, D, Préat, V, Optimisation of intradermal DNA electrotransfer for immunisation. J Control Release 124 (2007), 81–87.
44. 44 Gutowska-Owsiak, D, Ogg, GS, The epidermis as an adjuvant. J Invest Dermatol 132:3 Pt 2 (2012), 940–948.
45. 45 McKinney, EC, Streilein, JW, On the extraordinary capacity of allogeneic epidermal Langerhans cells to prime cytotoxic T cells in vivo. J Immunol 143 (1989), 1560–1564.
46. 46 He, Y, Zhang, J, Donahue, C, Falo, LD Jr, Skin-derived dendritic cells induce potent CD8(+) T cell immunity in recombinant lentivector-mediated genetic immunization. Immunity 24 (2006), 643–656.
47. 47 Heath, WR, Belz, GT, Behrens, GM, Smith, CM, Forehan, SP, Parish, IA, et al. Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens. Immunol Rev 199 (2004), 9–26.
48. 48 Hengge, UR, Walker, PS, Vogel, JC, Expression of naked DNA in human, pig, and mouse skin. J Clin Invest 97 (1996), 2911–2916.
49. 49 Romani, N, Thurnher, M, Idoyaga, J, Steinman, RM, Flacher, V, Targeting of antigens to skin dendritic cells: possibilities to enhance vaccine efficacy. Immunol Cell Biol 88 (2010), 424–430.
50. 50 Chung, DJ, Romano, E, Pronschinske, KB, Shyer, JA, Mennecozzi, M, St Angelo, ET, et al. Langerhans-type and monocyte-derived human dendritic cells have different susceptibilities to mRNA electroporation with distinct effects on maturation and activation: implications for immunogenicity in dendritic cell-based immunotherapy. J Transl Med, 11, 2013, 166.
51. 51 Yan, J, Yoon, H, Kumar, S, Ramanathan, MP, Corbitt, N, Kutzler, M, et al. Enhanced cellular immune responses elicited by an engineered HIV-1 subtype B consensus-based envelope DNA vaccine. Mol Ther 15 (2007), 411–421.
52. 52 Härle-Bachor, C, Boukamp, P, Telomerase activity in the regenerative basal layer of the epidermis inhuman skin and in immortal and carcinoma-derived skin keratinocytes. Proc Natl Acad Sci USA 93 (1996), 6476–6481.
53. 53 Robins, PG, Brandon, DR, A modification of the adenosine triphosphatase method to demonstrate epidermal Langerhans cells. Stain Technol 56 (1981), 87–89.